Daan Bosshardt1,2,3, Renske Merton1,2, Aart Nederveen1,2, Danielle Robbers-Visser3, Roland van Kimmenade4, Moniek Cox5, Eric Schrauben1, Maarten Groenink3, and Pim van Ooij1,2
1Radiology and Nuclear medicine, Amsterdam University Medical Centers, Amsterdam, Netherlands, 2Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands, 3Cardiology, Amsterdam University Medical Centers, Amsterdam, Netherlands, 4Cardiology, Radboud University Medical Center, Nijmegen, Netherlands, 5University Medical Center Groningen, Groningen, Netherlands
Synopsis
Keywords: Vascular, Blood vessels, Marfan
Motivation: New biomarkers are needed to guide aortic surgery to prevent aortic dissection in Marfan syndrome (MFS).
Goal(s): To investigate differences in aortic motion between healthy volunteers and (subgroups of) MFS patients.
Approach: We apply a recently published novel non-contrast enhanced, free breathing, time-resolved 3D balanced steady free precession CMR scan with a machine learning based algorithm for automatic aortic segmentations to evaluate 4D aortic motion.
Results: We found significant differences in aortic motion between patients with- and without a history of aortic root surgery and healthy volunteers. Thus, aortic motion might be a novel marker for aortic disease severity in MFS.
Impact: The differences in 4D aortic motion measured
using 3D CINE balanced steady state free precession CMR between healthy volunteers and (subgroups of)
Marfan syndrome patients might provide a new marker for disease severity in
Marfan syndrome.
Background
Aortic diameter is currently the only biomarker for elective aortic
surgery in Marfan Syndrome (MFS). However, some MFS patients still develop an aortic
dissection
before reaching this diameter threshold or in an aortic region distal to the operated
aortic root. Thus, we need new biomarkers to predict aortic
dissections. Abnormal distensibility and motion of the aorta may play a role in
aortic growth and dissection. We investigated 4D aortic motion as a
potential new biomarker for aortic disease severity in MFS using 4D balanced
steady-state free precession (bSSFP) cardiac magnetic resonance imaging (CMR). Methods
57
MFS patients (27 females, aged 35 ± 8.6 years, 31 with a history of aortic root
surgery) and 11 healthy volunteers (HV) (7 females, aged 31 ± 8.2
years) underwent imaging of the thoracic aorta using a non-contrast enhanced, free breathing,
time-resolved three dimensional (3D) CINE bSSFP sequence with Gaussian shaped RF pulse on an Ingenia
3T MRI scanner (Philips Healthcare, Best, Netherlands)1. PROspective Undersampling in multiple
Dimensions (PROUD) with acceleration factor R~10 was used resulting in a scan
time of ~4 minutes2. Scan parameters were FOV=256×256-320×70-88mm3
and slice oversampling factor=1.70-2.14, based on aortic geometry; acquired/reconstructed
spatiotemporal resolution = 1.6/1.0mm3, ~67ms (15 cardiac phases, [CP]),
TR/TE/FA=2.9ms/1.44ms/40°.
A previously described nnU-Net was used to automatically segment the
thoracic aorta in all CP3. For current analysis, the network was
retrained on previously acquired 84 manual segmentations from 14 healthy
volunteers and 10 new manual segmentations of randomly selected CP in MFS patient
data in the current cohort.
The time-resolved segmentations were used to derive 4D aortic diameter
maps4. For analysis, only the ascending aorta (AAo),
from the sinotubular junction to the mid-aortic arch, was considered. Mean displacement
and diameter change of the AAo were derived using an iterative closest point
registration of this single reference end-diastolic phase to all CP4, 5. End-systole was determined by visually
assessing the last CP showing left ventricular contraction. Subsequently, CP
were grouped for early-systole (1-2), peak-systole (3-4), late-systole (5-6) and
diastole (7-15). Figure 1 displays an overview of the entire acquisition and
processing pipeline. Additionally, mid-diastolic aortic diameters were manually
measured on cross-sections in a clinical 3D mDixon scan (spatial resolution: 1.25x1.25x1.25mm).
The Kruskal-Wallis test and Dunn’s test with Bonferroni correction for multiple
testing were used to compare differences in median motion parameters per
grouped CP for patients with a native aortic root (native MFS), patients with a
history of aortic root surgery (RR MFS) and for HV. Results
Baseline characteristics are presented in table
1. Typical examples of aortic motion of a HV and a native and a RR MFS patient are
displayed in figure 2. Figure 3 shows the mean AAo diameter, diameter
change and displacement over the cardiac cycle for MFS patients and HV. All
median values +/- IQR are presented in table 2. AAo diameter was significantly larger
for RR MFS patients versus native MFS patients and HV. Displacement was significantly larger for HV compared to RR MFS
patients and native MFS patients in peak- and late-systole and diastole. Native
MFS patients showed higher displacement in peak- and late-systole and diastole
compared to RR MFS patients. Mean AAo diameter change was larger for HV versus
native and RR MFS patients in peak- and late- systole and in diastole. Furthermore,
peak- and late-systole AAo diameter change was larger in native versus
RR MFS patients. AAo displacement (mm) was not different for MFS patients on
betablockers prescription versus patients without betablockers in any cardiac
phase (early-systole: 0.55(IQR: 0.26–0.90) vs
0.54(IQR: 0.36–1.00), p=0.980;
peak-systole: 2.82(IQR: 1.87–3.94) vs 3.15(IQR: 2.05–4.10), p=0.41,
late-systole: 4.05(IQR: 3.06–5.28) vs 4.42(IQR: 3.54–5.65), p=0.320; and diastole 1.43(IQR: 1.06–1.77)
vs 1.78(1.48–2.33), p=0.146. Age was
negatively associated with diameter change in late-systole in native MFS
patients (rs=-0.508, n=26, p=0.008).Discussion
Pathological
changes in the aortic wall in MFS syndrome and presence of a stiff aortic graft
seem to result in decreased bulk motion and diameter change in the AAo.
Clinical follow-up data is required to assess if this decreased bulk motion can
act as an independent marker to identify MFS aortas at high risk of dissection.
Furthermore, this work shows potential for future investigation of the
stress-strain relationship in the aortic wall by combining aortic movement data,
as measurement for strain, with a non-invasive method of measuring arterial
pressure, as marker for arterial stress. Conclusion
We showed
significant differences in aortic motion during the cardiac cycle between HV,
native MFS and RR MFS patients. These
findings may be useful for the monitoring of aortic disease in MFS. Acknowledgements
This study is part of the project "Comprehensive
assessment of 4D thoracic aorta biomechanics using novel cardiac MRI
technology" with project number 18402 of the research programme
"Applied and Engineering Sciences", which is partly financed by the
Dutch Research Council (NWO).References
1. Merton
R, Bosshardt D, Strijkers GJ, Nederveen AJ, Schrauben EM, van Ooij P.
Reproducibility of 3D thoracic aortic displacement from 3D cine balanced SSFP
at 3 T without contrast enhancement. Magn Reson Med. 2023.
2. Gottwald LM, Peper ES, Zhang Q,
Coolen BF, Strijkers GJ, Nederveen AJ, van Ooij P. Pseudo-spiral sampling and
compressed sensing reconstruction provides flexibility of temporal resolution
in accelerated aortic 4D flow MRI: A comparison with k-t principal component
analysis. NMR Biomed. 2020;33(4):e4255.
3. Merton R BD, Strijkers GJ, Nederveen
AJ, Schrauben EM, van Ooij P. 4D aortic motion maps from isotropic
high-resolution 3D CINE balanced steady state free precession at 3T and
automated segmentations. Joint Annual
Meeting ISMRM-ESMRMB & ISMRT 32st Annual Meeting; Toronto, Canada2023.
4. van Ooij P, Collins J, Fedak P,
Nederveen AJ, Carr JC, Markl M, Barker AJ. 3D Linear Regression Analysis
Reveals Relationships of 4D flow MRI-derived Aortic Dimensions with Age, Gender
and Wall Shear Stress in Patients with Aortopathy. Honolulu, Hawaii. 2017:288.
5. Audenaert
EA, Van Houcke J, Almeida DF, Paelinck L, Peiffer M, Steenackers G, Vandermeulen
D. Cascaded statistical shape model based segmentation of the full lower limb
in CT. Comput Methods Biomech Biomed Engin. 2019;22(6):644-57.